News from coherus biosciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

24 Sep, 2014, 22:55 BST Coherus BioSciences Appoints Mary Szela to Board of Directors

Coherus BioSciences, Inc., a late-stage biologics platform company focused on the global biosimilar market, announced today the appointment of Mary...


14 Aug, 2014, 23:02 BST Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study

Coherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a...


09 Jul, 2014, 13:00 BST Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors

Coherus BioSciences, Inc. ("Coherus"), announced today the appointment of V. Bryan Lawlis, Jr., Ph.D., former President and CEO of Itero...


07 Jan, 2014, 14:03 GMT Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference

Denny Lanfear, President and CEO of Coherus Biosciences, will present at the J.P. Morgan 32nd Annual Healthcare Conference on Wednesday, January 15...


28 Oct, 2013, 11:59 GMT Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study

Coherus Biosciences, Inc. today announced that its proposed etanercept biosimilar molecule, CHS-0214, an investigational drug, met the primary...


07 Jan, 2013, 13:00 GMT Coherus Announces Appointment of Dr. V. Bryan Lawlis, Jr. as Chairman of its Scientific Advisory Board

Coherus BioSciences, Inc. ("Coherus"), a biopharmaceuticals company dedicated to global development and commercialization of biologic therapeutics,...


22 Oct, 2012, 14:00 BST Coherus BioSciences Announces Appointment Of George G. Montgomery As Chief Financial Officer

Coherus BioSciences, Inc. ("Coherus"), a biopharmaceuticals company dedicated to global development and commercialization of biologic therapeutics,...


07 May, 2012, 18:47 BST Coherus BioSciences est lancé afin d'amener la nouvelle génération d'entreprises innovatrices au développement global et à la prestation de thérapies biologiques

Une équipe de direction composée de pionniers dans le secteur des biotechnologies qui a aidé à construire l'industrie bio thérapeutique en Amérique a ...


07 May, 2012, 14:00 BST Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates

Coherus BioSciences, Inc (hereafter, Coherus BioSciences) and Daiichi Sankyo, Co. Ltd. (hereafter, Daiichi Sankyo; TSE 4568) announced today the...


07 May, 2012, 14:00 BST Coherus BioSciences Launched To Bring Next-Generation Business Innovation To The Global Development And Delivery Of Biologic Therapies

An executive management team made up of early biotech pioneers who helped build America's biotherapeutics industry today announced the creation of...